Physician profile
Robert Hart
NPI 1750334900
$2,535.25
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,618 · 2020: $562 · 2021: $283 · 2022: $49.62 · 2023: $22.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $22.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $22.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $885.03 | 2019-2023 | Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $352.37 | 2019-2020 | |
| Genentech USA, INC. | $266.25 | 2019-2020 | |
| Grifols USA, LLC | $189.64 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $164.77 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $128.98 | 2019-2021 | |
| Harmony Biosciences LLC | $78.78 | 2020 | |
| Sunovion Pharmaceuticals INC. | $71.32 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $62.97 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $54.93 | 2019-2020 | |
| Ucb, INC. | $40.00 | 2019 | |
| Insmed, INC. | $33.90 | 2020 | |
| Vanda Pharmaceuticals INC. | $33.29 | 2020 | |
| Apria Healthcare LLC | $33.21 | 2021 | |
| Cerapedics INC. | $31.91 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $25.44 | 2019 | |
| Advanced Respiratory, INC | $20.22 | 2021 | |
| Breathe Technologies, INC. | $17.44 | 2019 | |
| Circassia INC. | $15.54 | 2019 | |
| Baxter Healthcare | $14.78 | 2021 | |
| Sandoz INC. | $14.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Hart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.